Syncom Formulations (India) Ltd Share Price
(SYNCOMF)
₹17.63
as on 02:03PM, 23 Apr 2025
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -2.08 % |
3 Month Return | -3.04 % |
1 Year Return | + 29.42 % |
Market Stats | |
Previous Close | ₹17.86 |
Open | ₹17.64 |
Volume | 13.22L |
Upper Circuit | ₹21.43 |
Lower Circuit | ₹14.28 |
Market Cap | ₹1,678.84Cr |
P/E Ratio
35.02
PEG Ratio
206
Market Cap
₹1,678.84 Cr
P/B Ratio
3.67
EPS
0.27
Dividend Yield
0Sector
Pharmaceuticals
ROE
8.71
Funds | Holdings | Prev. 5M |
---|---|---|
![]() | 0.06% |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 7 quarters, 4.4 Cr → 13.0 Cr (in ₹), with an average increase of 15.6% per quarter
Revenue Rich
Revenue is up for the last 7 quarters, 61.71 Cr → 131.57 Cr (in ₹), with an average increase of 11.7% per quarter
Retail Holding Up
Retail Investor have increased holdings from 49.30% to 49.32% in Mar 2025 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.57% of holdings in Mar 2025 quarter
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.6% return, outperforming this stock by 74.2%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 56.9% return, outperforming this stock by 27.4%
FII Holding Down
Foreign Institutions have decreased holdings from 0.13% to 0.11% in Mar 2025 quarter
Price Dip
In the last 1 month, SYNCOMF stock has moved down by -2.1%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 50.57% | 0.00 | |
Foreign Institutions | 0.11% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 49.32% | 0.00 | |
Others | 0% | 0.00 |
Syncom Formulations (India) Ltd in the last 5 years
Lowest (3.98x)
March 12, 2020
Today (35.02x)
April 22, 2025
Industry (53.69x)
April 22, 2025
Highest (81.74x)
January 18, 2022
Syncom Formulations (India) Ltd’s net profit jumped 85.71% since last year same period to ₹13Cr in the Q3 2024-2025. On a quarterly growth basis, Syncom Formulations (India) Ltd has generated 17.01% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending June 2022, Syncom Formulations (India) Ltd has declared dividend of ₹0.03 - translating a dividend yield of 0.17%.
Read More about DividendsBearish
Neutral
Bullish
Syncom Formulations (India) Ltd is currently in a Bullish trading position according to technical analysis indicators.
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹1,678.84 Cr | 337.2% | 0.61 | ₹25 Cr | ₹263 Cr | |
NA | ₹23.89 Cr | 106.42% | 0.50 | NA | NA | |
NA | ₹1,468.50 Cr | -5.28% | 0.62 | ₹57 Cr | ₹398 Cr | |
NA | ₹5,658.04 Cr | 452.63% | 0.50 | ₹33 Cr | ₹204 Cr | |
NA | ₹19.71 Cr | 404.56% | 0.50 | NA | NA |
Organisation | Syncom Formulations (India) Ltd |
Headquarters | Indore |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Syncom Formulations (India) Ltd share price today stands at ₹17.63, Open: ₹17.64, Previous Close: ₹17.86, High: ₹18.2, Low: ₹17.42, 52 Week High: ₹27.9, 52 Week Low: ₹10.95.
Today's traded volume of Syncom Formulations (India) Ltd(SYNCOMF) is 13.22L.
Today's market capitalisation of Syncom Formulations (India) Ltd(SYNCOMF) is ₹1678.84Cr.
Syncom Formulations (India) Ltd (SYNCOMF) share price is ₹17.63. It is down -36.81% from its 52 Week High price of ₹27.9
Syncom Formulations (India) Ltd (SYNCOMF) share price is ₹17.63. It is up 61.00% from its 52 Week Low price of ₹10.95